Verona Pharma Dividend

Dividend criteria checks 0/6

Verona Pharma does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.67
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Is Verona Pharma (NASDAQ:VRNA) Using Too Much Debt?

Apr 26
Is Verona Pharma (NASDAQ:VRNA) Using Too Much Debt?

Verona Pharma: A Few Points From The Bull And Bear Case

Feb 15

Is Verona Pharma (NASDAQ:VRNA) A Risky Investment?

Jan 26
Is Verona Pharma (NASDAQ:VRNA) A Risky Investment?

Verona Pharma: Upcoming PDUFA, Expired Patent, Strong Data

Jan 19

Health Check: How Prudently Does Verona Pharma (NASDAQ:VRNA) Use Debt?

Oct 12
Health Check: How Prudently Does Verona Pharma (NASDAQ:VRNA) Use Debt?

Does Verona Pharma (NASDAQ:VRNA) Have A Healthy Balance Sheet?

Jun 27
Does Verona Pharma (NASDAQ:VRNA) Have A Healthy Balance Sheet?

Verona Pharma (NASDAQ:VRNA) Has Debt But No Earnings; Should You Worry?

Mar 10
Verona Pharma (NASDAQ:VRNA) Has Debt But No Earnings; Should You Worry?

Is Verona Pharma (NASDAQ:VRNA) Using Debt In A Risky Way?

Dec 02
Is Verona Pharma (NASDAQ:VRNA) Using Debt In A Risky Way?

Verona: Expected End Of 2022 Catalyst Could Provide Value Inflection Point

Sep 13

Verona stock rises as partner Nuance gets China regulator nod to start lung disease drug trials

Aug 19

Verona Pharma GAAP EPS of -$0.04 beats by $0.23

Aug 09

Verona Pharma: First Inhaled Product Candidate Combining Anti-Inflammatory And Bronchodilator Effects, A Potential Blockbuster

Feb 04

Verona Pharma's ensifentrine successful in mid-stage lung disease study; shares up 8%

Feb 02

Enrollment completed in Verona Pharma's study of pMDI ensifentrine in COVID-19

Jan 14

Verona Pharma EPS beats by $0.15

Oct 29

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VRNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VRNA's dividend payments have been increasing.


Dividend Yield vs Market

Verona Pharma Dividend Yield vs Market
How does VRNA dividend yield compare to the market?
SegmentDividend Yield
Company (VRNA)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast in 3 Years (VRNA)n/a

Notable Dividend: Unable to evaluate VRNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VRNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate VRNA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VRNA has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.